Central nervous system relapse in a patient with acute promyelocytic leukaemia treated with arsenic tri-oxide.
Mathews
V
V
Balasubramanian
P
P
Shaji
R V
RV
George
B
B
Chandy
M
M
Srivastava
A
A
D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D001151:Arsenic / Q000378:metabolism; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000378:metabolism / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000276:immunology* / Q000378:metabolism; D002831:Choroid Plexus / Q000378:metabolism; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D010087:Oxides / Q000378:metabolism / Q000627:therapeutic use*; D012008:Recurrence
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D001151:Arsenic; D000077237:Arsenic Trioxide